$2,590.00

RPMI-8226 SMAD/TGFbeta Reporter (Luc) stable cell line

Catalog number
CL-1459
Description
RPMI-8226 SMAD/TGFbeta Reporter (Luc) cells are derived from the human myeloma RPMI-8226 cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. The RPMI-8226 cell line is a valuable tool for understanding multiple myeloma and developing new treatments, including CAR-T (chimeric antigen receptor T-cell) therapy. RPMI-8226 SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGF?/SMAD signaling pathway.

Product Details

Package Size 2 x 10^6 cells
Parental cell line RPMI-8226 cells
Transgenic gene Firefly luciferase
Mammalian selection Puromycin
Biosafety level 2
Storage Liquid nitrogen
Availability 3-4 weeks
Shipping condition dry ice
Copyright © 2025, FenicsBIO. All rights reserved.